Viatris gets USFDA tentative nod for paediatric formulation of Abacavir, Dolutegravir, Lamivudine for children with HIV Ruchika Sharma5 Sept 2023 3:54 PM ISTBangalore: Viatris Inc., a global healthcare company, today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug...
Aurobindo Pharma arm signs voluntary license with Medicines Patent Pool to develop generic version of Nilotinib Capsules for chronic myeloid leukemia treatment in 44 countries Ruchika Sharma23 Jun 2023 11:51 AM ISTHyderabad: Pharma major, Aurobindo Pharma Limited, has announced that its wholly-owned subsidiary company, Eugia Pharma Specialities Limited, has...
Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug Ruchika Sharma31 March 2023 3:09 PM ISTAurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.
Novartis allows generic Leukemia drug production in 7 nations: Bloomberg Ruchika Sharma21 Oct 2022 2:35 PM ISTChronic myeloid leukemia is a cancer that starts in the blood-forming cells found in bone marrow, before spilling into the general blood stream.
Granules India Receives Licences from MPP to Market generic of Pfizers Paxlovid MD Bureau21 March 2022 11:46 AM ISTThe product will be made at Granules manufacturing facilities in India that are approved by global regulatory agencies including USFDA. The license...
COVID-19: 35 pharma cos to mass product generic version of Pfizer's Paxlovid MD Bureau18 March 2022 6:16 PM ISTIn India, Hyderabad-based pharma major Aurobindo Pharma has signed the agreement.
Strides Pharma, Medicines Patent Pool ink pact to commercialize molnupiravir for global markets Ruchika Sharma24 Jan 2022 9:00 AM ISTBengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has recently announced its partnership with Medicines Patent Pool (MPP)...
Natco Pharma inks pact with MPP to sell Molnupiravir capsules Dr. Divya Colin22 Jan 2022 3:35 PM ISTNatco said with this licence agreement it can manufacture and sell Molnupiravir capsules 200 mg for Indian market, which will be sold under brand name...
Biophore India gets MPP licence to market molnupiravir Dr. Divya Colin22 Jan 2022 3:14 PM ISTNew Delhi: Biophore India Pharmaceuticals on Thursday said it has received licences from Medicines Patent Pool (MPP) on behalf of originator company...
Pfizer, Medicines Patent Pool ink pact to expand Covid-19 oral antiviral treatment access Ruchika Sharma17 Nov 2021 11:00 AM ISTNew York: Pfizer Inc. and the Medicines Patent Pool (MPP), have recently announced the signing of a voluntary license agreement for Pfizer's...
Merck to share molnupiravir formula with poor countries, enters agreement with MPP Ruchika Sharma28 Oct 2021 5:23 PM ISTGeneva: To ensure the affordable global access for molnupiravir, pharma giant Merck (MSD) has entered into a voluntary licencing...
